Catalog Number D134801 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Cardiac Arrest (1762); Cardiac Tamponade (2226)
|
Event Date 08/01/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Device investigation details: information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 31049385l number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.E1.Initial reporter phone: (b)(6).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Event Description
|
It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient suffered a cardiac arrest and cardiac tamponade requiring a pericardiocentesis.It was reported that they approached from left ventricular to premature ventricular contraction (pvc)s of right ventricular outflow tract origin (approximately 120 minutes after the start of the procedure and 60 minutes after the initial ablation).The patient complained of chest pain during left ventricular wall ablation.Heart rate was maintained, but blood pressure decreased, and consciousness was impaired.According to ekg ii.Avf, there was a finding of st depression.Emergency treatment such as cardiac massage and administering a vasopressor were performed, and the vitals returned stable.Then coronary angiography was performed without any problems.Finally, the patient was found to have cardiac tamponade by echocardiography.Necessary intervention such as pericardial cardiac drainage etc.Was performed and the patient returned to the ward.Vitals recovered to normal.Heart rate, blood pressure, and spo2 were all normal.The patient returned to the ward in a clear and communicative state of consciousness.The patient¿s outcome from the adverse event was reported as improved.The physician assessment of the health hazard was that it was serious and causally related to the product.Per the physician, we did not know the cause of this event, which occurred despite the fact that the same method was used to ablate only those areas (ventricular walls) where ablation would not cause a problem.During the ablation, there was no abnormalities or discomfort.There were no abnormalities observed prior to and during use of the product.Atrial septal puncture was not performed.The adverse event was discovered during use of biosense webster products and ablation had already been performed before cardiac tamponade was confirmed.Steam pop was not confirmed.The correct catheter settings selected on the smartablate generator in a standard setting and flow rate setting was low flow 2ml/min,~30w 8ml/min, 31w 15ml/min.The pump switching from ¿low¿ to ¿high¿ flow during ablation.Method of contact force monitoring included real time graph; dashboard; vector and visitag.Coloring settings for visitag included tag index.Visitag additional filters were force over time (fot).No error messages observed on biosense webster equipment during the procedure.
|
|
Search Alerts/Recalls
|
|